Funded Tech Companies
Amylyx Pharmaceuticals
Looking for the VC firms that provided funding to Amylyx Pharmaceuticals? Morningside Group, 683 Capital and Polaris Founders Capital put venture money into this innovative biopharmaceutical company.
Company Overview
Company Name
Amylyx Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
43 Thorndike St.
Cambridge, MA 02141
USA
Cambridge, MA 02141
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Amylyx is an IND-enabling stage biopharmaceutical company dedicated to providing innovative, disease-modifying solutions for neurodegenerative diseases. We have a highly creative and motivated team focused on streamlined clinical development and drug discovery.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/7/2022
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Joshua Cohen
Chief Executive Officer
Justin Klee
Chief Financial Officer
James Frates
Chief Medical Officer
Patrick Yeramian
Chief Scientific Officer
Kent Leslie
VP - Bus. Development
Margaret Olinger
VP - Human Resources
Debra Canner
Company Investors
- Morningside Group (Isaac Cheng)
- 683 Capital
- Polaris Founders Capital
- Rock Springs Capital
- Tybourne Capital Management
- Bain Capital Life Sciences
- aMoon Partners
- Viking Global Investors
- Marshall Wace
- Alpha Wave Ventures
- Perceptive Advisors
- Woodline Partners
- Verition Fund Management
- Private Investors (Belinda Termeer)
- Private Investors (Henri Termeer)
Browse more funded tech companies:
Amylin Pharmaceuticals | Amyris
Share this article
About Our VC & M&A Database
This venture capital transaction data comes via a partnership with VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs